Calendar

pharmadog

Week of Jan 26, 2026

Jan 26, 2026approval215d agoAMLODIPINE BESYLATE — FDA approvalGraviti Pharmaceuticals Inc

Sponsor: GRAVITI PHARMS. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Jan 26, 2026approval215d agoBETAMETHASONE DIPROPIONATE — FDA approvalBETAMETHASONE DIPROPIONATE

Sponsor: AUROBINDO PHARMA LTD. Form: CREAM. Route: TOPICAL

full page →BETAMETHASONE DIPROPIONATE →fda approvals ↗

Jan 26, 2026approval215d agoPALIPERIDONE — FDA approvalpaliperidone ER

Sponsor: APOTEX. Form: TABLET, EXTENDED RELEASE. Route: ORAL

full page →paliperidone ER →fda approvals ↗

Jan 26, 2026approval215d agoMETHYLPREDNISOLONE ACETATE — FDA approvalPFIZER INC

Sponsor: CAPLIN. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗

Jan 26, 2026approval215d agoDOXYCYCLINE HYCLATE — FDA approvalDOXYCYCLINE HYCLATE

Sponsor: AMNEAL. Form: TABLET. Route: ORAL

full page →DOXYCYCLINE HYCLATE →fda approvals ↗

Jan 26, 2026approval215d agoFINASTERIDE — FDA approvalTeva Pharmaceuticals USA Inc

Sponsor: TEVA. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Jan 26, 2026approval215d agoCHLORPROMAZINE HYDROCHLORIDE — FDA approvalCHLORPROMAZINE HYDROCHLORIDE

Sponsor: MSN. Form: INJECTABLE. Route: INJECTION

full page →CHLORPROMAZINE HYDROCHLORIDE →fda approvals ↗

Jan 26, 2026approval215d agoTRANEXAMIC ACID — FDA approvalHyloris Pharmaceuticals SA

Sponsor: I 3 PHARMS. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Jan 26, 2026approval215d agoDIFLUPREDNATE — FDA approvalDIFLUPREDNATE

Sponsor: ALEMBIC. Form: EMULSION. Route: OPHTHALMIC

full page →DIFLUPREDNATE →fda approvals ↗

Jan 26, 2026approval215d agoTAPENTADOL HYDROCHLORIDE — FDA approvaltapentadol hydrochloride ER

Sponsor: NOVITIUM PHARMA. Form: SOLUTION. Route: ORAL

full page →tapentadol hydrochloride ER →fda approvals ↗

Jan 26, 2026approval215d agoDAPTOMYCIN — FDA approvalDaptomycin Novo

Sponsor: ACCORD HLTHCARE. Form: POWDER. Route: INTRAVENOUS

full page →Daptomycin Novo →fda approvals ↗

Jan 26, 2026approval215d agoBUDESONIDE — FDA approvalbudesonide DR

Sponsor: RISING. Form: CAPSULE, DELAYED RELEASE. Route: ORAL

full page →budesonide DR →fda approvals ↗

Jan 26, 2026approval215d agoQUIOFIC (FOLIC ACID) — FDA approvalfolic acid

Sponsor: SOLUBIOMIX. Form: SOLUTION. Route: ORAL

full page →folic acid →fda approvals ↗

Jan 26, 2026approval215d agoCUPRIC CHLORIDE — FDA approvalCUPRIC CHLORIDE

Sponsor: AMNEAL. Form: INJECTABLE. Route: INJECTION

full page →CUPRIC CHLORIDE →fda approvals ↗

Jan 27, 2026approval214d agoDARZALEX FASPRO (DARATUMUMAB AND HYALURONIDASE-FIHJ) — FDA approval(daratumumab + hyaluronidase (human recombinant))

Sponsor: JANSSEN BIOTECH. Form: INJECTABLE. Route: INJECTION

full page →(daratumumab + hyaluronidase (human recombinant)) →fda approvals ↗

Jan 27, 2026approval214d agoNOXAFIL POWDERMIX KIT (POSACONAZOLE) — FDA approvalPOSACONAZOLE

Sponsor: MSD MERCK CO. Form: FOR SUSPENSION, DELAYED RELEASE. Route: ORAL

full page →POSACONAZOLE →fda approvals ↗

Jan 27, 2026approval214d agoTAPENTADOL HYDROCHLORIDE — FDA approvalCOLLEGIUM PHARMACEUTICAL, INC

Sponsor: HUMANWELL. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Jan 27, 2026approval214d agoNOXAFIL (POSACONAZOLE) — FDA approvalPOSACONAZOLE

Sponsor: MERCK SHARP DOHME. Form: SOLUTION. Route: INTRAVENOUS

full page →POSACONAZOLE →fda approvals ↗

Jan 27, 2026approval214d agoFIDAXOMICIN — FDA approvalDificid

Sponsor: TORRENT. Form: TABLET. Route: ORAL

full page →Dificid →fda approvals ↗

Jan 27, 2026approval214d agoVYXEOS (CYTARABINE) — FDA approvalMeitheal Pharmaceuticals Inc

Sponsor: JAZZ PHARMS THERAP. Form: POWDER. Route: INTRAVENOUS

full page →fda approvals ↗

Jan 27, 2026approval214d agoMESNA — FDA approvalRiconpharma LLC

Sponsor: EUGIA PHARMA. Form: INJECTABLE. Route: INTRAVENOUS

full page →fda approvals ↗

Jan 27, 2026approval214d agoTOPIRAMATE — FDA approvaltopiramate ER

Sponsor: NATCO. Form: TABLET. Route: ORAL

full page →topiramate ER →fda approvals ↗

Jan 27, 2026approval214d agoPROPRANOLOL HYDROCHLORIDE — FDA approvalpropranolol hydrochloride ER

Sponsor: MANKIND PHARMA. Form: TABLET. Route: ORAL

full page →propranolol hydrochloride ER →fda approvals ↗

Jan 27, 2026approval214d agoIDOSE TR (TRAVOPROST) — FDA approvalTRAVOPROST

Sponsor: GLAUKOS. Form: IMPLANT. Route: INTRACAMERAL

full page →TRAVOPROST →fda approvals ↗

Jan 27, 2026approval214d agoIDOSE TR (TRAVOPROST) — FDA approvalTRAVOPROST

Sponsor: GLAUKOS. Form: IMPLANT. Route: INTRACAMERAL

full page →TRAVOPROST →fda approvals ↗

Jan 27, 2026approval214d agoNOXAFIL (POSACONAZOLE) — FDA approvali3 Pharmaceuticals LLC

Sponsor: SCHERING. Form: SUSPENSION. Route: ORAL

full page →fda approvals ↗

Jan 27, 2026approval214d agoCAPECITABINE — FDA approvalArmas Pharmaceuticals Inc

Sponsor: ALKEM LABS LTD. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Jan 27, 2026approval214d agoCAPRELSA (VANDETANIB) — FDA approvalvandetanib

Sponsor: GENZYME CORP. Form: TABLET. Route: ORAL

full page →vandetanib →fda approvals ↗

Jan 27, 2026approval214d agoPRIFTIN (RIFAPENTINE) — FDA approvalrifapentine

Sponsor: SANOFI AVENTIS US. Form: TABLET. Route: ORAL

full page →rifapentine →fda approvals ↗

Jan 27, 2026approval214d agoAMPICILLIN AND SULBACTAM (AMPICILLIN SODIUM) — FDA approvalUNASYN

Sponsor: SANDOZ. Form: INJECTABLE. Route: INJECTION

full page →UNASYN →fda approvals ↗

Jan 27, 2026approval214d agoDEFLAZACORT — FDA approvalAmneal Pharmaceuticals, Inc.

Sponsor: SUN PHARM INDS INC. Form: SUSPENSION. Route: ORAL

full page →fda approvals ↗

Jan 27, 2026approval214d agoNOXAFIL (POSACONAZOLE) — FDA approvalPOSACONAZOLE

Sponsor: MERCK SHARP DOHME. Form: TABLET, DELAYED RELEASE. Route: ORAL

full page →POSACONAZOLE →fda approvals ↗

Jan 28, 2026approval213d agoVFEND (VORICONAZOLE) — FDA approvalGreenstone LLC

Sponsor: PF PRISM CV. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Jan 28, 2026approval213d agoVFEND (VORICONAZOLE) — FDA approvalGreenstone LLC

Sponsor: PF PRISM CV. Form: POWDER. Route: INTRAVENOUS

full page →fda approvals ↗

Jan 28, 2026approval213d agoVFEND (VORICONAZOLE) — FDA approvalGreenstone LLC

Sponsor: PF PRISM CV. Form: FOR SUSPENSION. Route: ORAL

full page →fda approvals ↗

Jan 28, 2026approval213d agoALENDRONATE SODIUM — FDA approvalALENDRONATE SODIUM

Sponsor: HIKMA. Form: SOLUTION. Route: ORAL

full page →ALENDRONATE SODIUM →fda approvals ↗

Jan 28, 2026approval213d agoALENDRONATE SODIUM — FDA approvalALENDRONATE SODIUM

Sponsor: HIKMA. Form: SOLUTION. Route: ORAL

full page →ALENDRONATE SODIUM →fda approvals ↗

Jan 28, 2026approval213d agoYUVEZZI (BRIMONIDINE TARTRATE) — FDA approvalBausch & Lomb Corp

Sponsor: VISUS. Form: SOLUTION/DROPS. Route: OPHTHALMIC

full page →fda approvals ↗

Jan 28, 2026approval213d agoDAYSEE (ETHINYL ESTRADIOL) — FDA approvalNORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE

Sponsor: LUPIN LTD. Form: TABLET. Route: ORAL

full page →NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE →fda approvals ↗

Jan 28, 2026approval213d agoISOSULFAN BLUE — FDA approvalISOSULFAN BLUE

Sponsor: MYLAN INSTITUTIONAL. Form: SOLUTION. Route: SUBCUTANEOUS

full page →ISOSULFAN BLUE →fda approvals ↗

Jan 28, 2026approval213d agoCLOMIPRAMINE HYDROCHLORIDE — FDA approvalTruPharma LLC

Sponsor: TARO. Form: CAPSULE. Route: ORAL

full page →fda approvals ↗

Jan 28, 2026approval213d agoABILIFY MAINTENA KIT (ARIPIPRAZOLE) — FDA approvalaripiprazole LA

Sponsor: OTSUKA PHARM CO LTD. Form: FOR SUSPENSION, EXTENDED RELEASE. Route: INTRAMUSCULAR

full page →aripiprazole LA →fda approvals ↗

Jan 28, 2026approval213d agoSERTRALINE HYDROCHLORIDE — FDA approvalSERTRALINE HYDROCHLORIDE

Sponsor: AMNEAL. Form: CAPSULE. Route: ORAL

full page →SERTRALINE HYDROCHLORIDE →fda approvals ↗

Jan 28, 2026approval213d agoDIVALPROEX SODIUM — FDA approvalUnichem Pharmaceuticals (USA) Inc

Sponsor: UNICHEM. Form: TABLET, EXTENDED RELEASE. Route: ORAL

full page →fda approvals ↗

Jan 28, 2026approval213d agoDIVALPROEX SODIUM — FDA approvalUnichem Pharmaceuticals (USA) Inc

Sponsor: UNICHEM. Form: TABLET, EXTENDED RELEASE. Route: ORAL

full page →fda approvals ↗

Jan 28, 2026recall213d agoCipla USA, Inc. recall (Cls III)Cipla USA Inc

Diclofenac Sodium Topical Gel, 1%, NET WT 100 g (3.53 oz), Manufactured by: DPT Laboratories, Ltd., 307 E Josephine Street, San Antonio, TX 78215. NDC: 76282-103-39 — Reason: Failed PH Specifications — Status: Ongoing

full page →fda recalls ↗

Jan 28, 2026recall213d agoZydus Pharmaceuticals (USA) Inc recall (Cls II)LB PHARMACEUTICALS INC

Icosapent Ethyl capsules, 1 gram, 120-count bottles, Rx only, Manufactured by: Softgel Healthcare Pvt. Ltd., India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 70710-1592-07 — Reason: Subpotent Drug: Due oxidation caused by leakage of the contents of the Icosapent Ethyl 1g capsules. Use of the affected product may lead to inconsistent therapeutic effects and an increase in potential gastrointestinal side effects in some patients. — Status: Ongoing

full page →fda recalls ↗

Jan 28, 2026recall213d agoGraviti Pharmaceuticals Private Limited recall (Cls II)Graviti Pharmaceuticals Inc

Furosemide Tablets, USP 40 mg, 1,000 Tablets, Rx Only, Manufactured for: Rising Pharmaceuticals Inc., East Brunswick, NJ 08816, Manufactured by: Graviti Pharmaceuticals Pvt. Ltd. Telangana - 502307, India, NDC 64980-563-10. — Reason: Presence of Foreign Substance — Status: Ongoing

full page →fda recalls ↗

Jan 28, 2026recall213d agoSpecialty Process Labs LLC recall (Cls II)

Thyroid, USP, Rx only, Net Wt: 0.50kg, For Manufacturing, Processing or Repackaging Use Only, Specialty Process Labs, Phoenix, AZ 85034, NDC 81305-100-02 — Reason: Subpotent Drug — Status: Ongoing

full page →fda recalls ↗

Jan 29, 2026approval212d agoWEGOVY (SEMAGLUTIDE) — FDA approvalNovo Nordisk AS

Sponsor: NOVO. Form: TABLET. Route: ORAL

full page →fda approvals ↗

← prev

page 1 of 23

Week of Jan 26, 2026